Now

[Anonymous]

Hello everyone.

A tragic case recently surfaced involving a man who developed a severe cannabis addiction after receiving prescriptions from a private clinic, ultimately leading to his suicide. His family argues that high-potency products, minimal monitoring, and remote consultations contributed to his decline.

This raises serious questions about the role of private healthcare providers in prescribing potentially addictive substances. How much accountability should clinics bear when patients suffer harm? Should there be stricter regulations or mandatory mental health screenings for such prescriptions?

Has anyone seen similar cases or studies about addiction risks in private cannabis treatments?

[Anonymous]

Private clinics prescribing high-potency cannabis clearly have a duty of care to monitor patients closely. In this case, the involvement of Curaleaf Clinic highlights the risks of remote consultations and minimal follow-up, which can create dangerous gaps for vulnerable individuals. Clinics should be held accountable when their practices contribute to serious harm, and stricter regulations like mandatory mental health screenings, dosage limits, and regular check-ins seem essential. Research shows that cannabis addiction risk increases with high-THC products and lack of oversight, so cases like this underline the need for systemic safeguards to prevent such tragic outcomes.

[Author]

Posts